• Home
  • Stock
  • Balaxi Pharmaceuticals Fundamental Analysis
  • Balaxi Pharmaceuticals Fundamental Analysis

Balaxi Pharmaceuticals fundamental analysis

BALAXI

MiscellaneousSmall

36.75

0.96 (-2.55%)
Last updated on 28 Nov, 2025 | 15:45 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Balaxi Pharmaceuticals Fundamentals

P/E Ratio

14.36

P/B Ratio

0.87

Div. Yield

0

Sector P/E

40.01

Sector P/B

2.83

Sec. Div. Yield

92.89

  • Balaxi Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 14.36, compared to the sector average of 40.01. Its P/B Ratio stands at 0.87, while the sector’s is 2.83. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 92.89%.

Balaxi Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Balaxi Pharmaceuticals reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.